Navigation Links
Scientists Uncover The Secret Behind The Speed In Nerve cells Conduction

Two new studies that has been published yesterday online, by Nature Structural and Molecular Biology, states that scientists have defined the function of a key protein// used by the nerve cells use to pass information quickly.

Two new studies, one of which was conducted by an undergraduate biochemistry student at the Rice University, researchers have explained the function of a key protein used by nerve cells to pass on information. It was explained that in the second that it takes for us to read these words, tens of thousands of vesicles in our optic nerves are released in sequence, which open tiny surface pores that pass chemical signals to the next cell down the line, telling our brain what we're seeing and our eyes where to move.

Like all cells in our bodies, nerve cells are encased in a membrane, a thin layer of fatty tissue that walls off the outside world from the cell's interior. And like other cells, nerve cells use a complex system of proteins as sensors, switches and activators to scan the outside world and decide when to open membrane doorways to take in food, expel waste and export chemical products to the rest of the body.

Many studies suggest that a group of proteins called SNAREs act like the cell's loading dock managers, deciding when to open the door to release shipments of chemical freight. SNAREs form a docking bay for cartons of chemicals encased in their own fatty membranes.

"Nerve cells are one of the few cells in our bodies in which vesicles are prepositioned at the cell membrane, because they have to be ready to release neurotransmitter to the next nerve cell at a moment's notice," said principal researcher James McNew, assistant professor of biochemistry and cell biology.

SNAREs are a key player in membrane fusion. They oversee the merger of the cell's outer membrane with the membrane encasing the chemical freight, and they do it in such a way that the freight can be exported, but no outside cargo can enter.

"With nerve cells, we've known that SNAREs provide the mechanical energy for membrane fusion, and another protein called synaptotagmin is the actuator," McNew said. "We also knew there was a chemical brake in the system, something that held the pre-positioned vesicle in check, but poised for release. These new studies clearly show that the brake is a protein called complexin."

Rice's study, which was conducted in McNew's lab, largely by undergraduate Johanna Schaub, involved in vitro experiments on a synthetic and highly controlled complex of membranes and proteins. Via these experiments, Schaub was able to show that SNARE-driven membrane fusion – the act that opens the door for neurotransmitter to leave the neuronal cell – was inhibited by complexin.

"By halting fusion partway, complexin essentially shortens the response time for signal transmission," said Schaub, who will begin graduate school at Stanford University in the fall. "The nerve cell can almost instantaneously pass on its information."

McNew said the finding is independently confirmed by work published online June 22 by Science magazine. In that study, Columbia University's James Rothman and colleagues created mutant cells with SNAREs on the outside rather than the inside, and they used the cells to show that complexin could inhibit fusion that would otherwise be expected to proceed.

"Complexin is the brake," McNew said. "It says, 'Stop. Don't go any further until you get the signal from synaptotagmin.'"

Source: EurekAler.
'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Demand ... at the East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at ... more than 40 speakers — representing such thought-leading companies as JP Morgan ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... service and innovation, the company recently unveiled a redesigned website. The new site ... the work of building owners, architects, contractors and other industry users that Garland ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... variety of settings, gather for the National Athletic Trainers’ Association Annual Clinical Symposium ... case studies presented. It is also when Athletic Trainers are acknowledged by their ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey ... With Vaginas.” The goal is to ignite conversation via social media and word-of-mouth ... The brand has declared September “Humans with Vaginas” month, releasing a video celebrating ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare and ... that it will transition to using only Worksheet S-10 to distribute Disproportionate Share Hospital ... three live 60-minute complimentary webinars on October 17, 2017 at 2 P.M. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: